ANIP : Summary for ANI Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

ANI Pharmaceuticals, Inc. (ANIP)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
59.07-0.46 (-0.77%)
At close: 4:00PM EST
People also watch
AMAGENTAAGIOANACHZNP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close59.53
Open59.23
Bid55.60 x 300
Ask66.77 x 200
Day's Range58.45 - 60.12
52 Week Range30.15 - 70.92
Volume144,948
Avg. Volume125,786
Market Cap684.05M
Beta3.09
PE Ratio (TTM)86.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®

    BAUDETTE, Minn., Feb. 24, 2017 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today announced that it has acquired Inderal® XL from Cranford Pharmaceuticals, LLC and InnoPran XL®  from Holmdel Pharmaceuticals LP.  The acquired assets include the NDA and trademark for InnoPran XL® including a license to an Orange Book listed patent, and a distribution license and trademark for Inderal® XL as well as finished goods inventory of both products.  Inderal® XL and InnoPran XL® are currently available in 80mg and 120mg sustained release capsules and are indicated for hypertension.  Inderal® XL and InnoPran XL® generated combined sales of $23.3 million in calendar year 2016, according to IMS Health.  The acquisitions were funded through a combination of cash and debt. In conjunction with today's announcement, ANI has immediately begun selling both Inderal® XL 80mg and 120mg sustained release capsules as well as InnoPran XL® 80mg and 120mg sustained release capsules under their current labels.  ANI will transition both products to the ANI label at a future date.

  • PR Newswire10 days ago

    ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2016 Financial Results and 2017 Guidance

    BAUDETTE, Minn., Feb. 16, 2017 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2016 financial results and 2017 ...

  • ANI Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ANIP-US : February 1, 2017
    Capital Cube25 days ago

    ANI Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ANIP-US : February 1, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ANI Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)